AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Price
Price of AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Today
The live price of AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) is $0.044356.The current market capitalization stands at $44,356.00, with a 24-hour trading volume of $17.76.AB4AD (Antibodies for Alzheimer's Disease) has experienced +0.00% in the last 24 hours and has a circulating supply of approximately 1.00M.These figures are updated in real-time to provide the most accurate market data.
AB4AD Price Data
AB4AD Market Stats
News
MoreAB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Academy
More
AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Blog
More
AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Conversion Rate
AB4AD (Antibodies for Alzheimer's Disease) (AB4AD) Price Movements
| Period | Amount Change | Change (%) |
|---|---|---|
| Today | +$0.00 | +0.00% |
| 7 Days | +$0.00 | +0.00% |
| 30 Days | +$0.00 | +0.00% |
Disclaimer
Cryptocurrency prices are highly susceptible to market risk and volatility. You should invest only in products you are familiar with and fully understand the associated risks. The information provided on this page is for informational purposes only and does not constitute investment advice. It is not a recommendation to buy or sell any specific digital asset or adopt any particular investment strategy. Phemex makes no claims regarding the accuracy, suitability, or validity of any information provided or any particular asset. For further information, please refer to our Terms of Use and Risk Disclosure.
Please be aware that data related to the aforementioned cryptocurrency (such as its current live price) is derived from third-party sources. It is presented to you "as is" for informational purposes only, without any representation or warranty of any kind. Links to third-party sites are not under Phemex’s control. The content expressed on this page is not intended to and should not be construed as an endorsement by Phemex of the reliability or accuracy of such content. For further information, please refer to our Terms of Use and Risk Disclosure.